SCHEMBL27259792

SCHEMBL27259792

CC(C)(C)OC(=O)Nc1cc(F)cc(Cl)n1

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ATR Q13535 1/20 0.43
SCN9A Q15858 1/20 0.40
GSK3B P49841 1/20 0.39
DYRK1A Q13627 1/20 0.39
LCK P06239 4/20 0.38
CDK9 P50750 1/20 0.37
STK17B O94768 1/20 0.37
STK17A Q9UEE5 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
MAPKAPK2 P49137 2/20 0.36
CYP17A1 P05093 1/20 0.36
SYK P43405 1/20 0.36
S1PR2 O95136 1/20 0.36
RORC P51449 1/20 0.36
PTGER1 P34995 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30895246 1.00 ATR (0.43) ATRSCN9AGSK3BDYRK1ALCK
SCHEMBL16147173 0.84 ATR (0.45) ATRSCN9AGSK3BDYRK1ALCK
SCHEMBL31248850 0.84 ATR (0.45) ATRSCN9AGSK3BDYRK1ALCK
SCHEMBL25250667 0.82 GPR35 (0.43) ATRSCN9AGSK3BDYRK1ALCK
SCHEMBL29703935 0.81 SCN9A (0.40) SCN9AGSK3BDYRK1ALCKCDK9
SCHEMBL30931841 0.81 ATR (0.48) ATRSCN9AGSK3BDYRK1ALCK
SCHEMBL21551425 0.81 ATR (0.48) ATRSCN9AGSK3BDYRK1ALCK
SCHEMBL4443611 0.80 LCK (0.41) ATRSCN9AGSK3BDYRK1ALCK
SCHEMBL22028916 0.79 ATR (0.44) ATRSCN9AGSK3BDYRK1ALCK
SCHEMBL4438011 0.79 ATF1 (0.42) ATRSCN9AGSK3BDYRK1ALCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024091538-A1 COMPOUNDS AND COMPOSITIONS AS GPR52 MODULATORS NEUROCRINE BIOSCIENCES, INC. (US) 2024-05-02 WO disclosed
WO-2024091541-A1 COMPOUNDS AND COMPOSITIONS AS GPR52 MODULATORS NEUROCRINE BIOSCIENCES, INC. (US) 2024-05-02 WO disclosed
WO-2024091541-A1 COMPOUNDS AND COMPOSITIONS AS GPR52 MODULATORS NEUROCRINE BIOSCIENCES, INC. (US) 2024-05-02 WO disclosed